The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,183,962 in first-year total cost, median $591,981.
Most frequent study sections
- Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]1
- Vaccines Against Microbial Diseases Study Section[VMD]1
Most frequent institutions
- HARVARD PILGRIM HEALTH CARE, INC.1
- ROCKEFELLER UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | The yellow fever vaccine saga: Defining the viral and host determinants responsible for success versus failure1R01AI124690-01 | RICE, CHARLES M | ROCKEFELLER UNIVERSITY, NY | $790,963 | VMD |
| 2014 | Methods for Safety Evaluation of Vaccination Schedules1R01AI107721-01 | KULLDORFF, MARTIN | HARVARD PILGRIM HEALTH CARE, INC., MA | $392,999 | IRAP |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.